Biobanco de Enfermedades Infecciosas (BBEI), Argentina

Registration Status: Pending

Objective: Contribute to the advancement of scientific knowledge of Infectious Diseases within the coordinated action between INBIRS researchers and health centers of the Argentine Republic. This allows the development of interdisciplinary research projects in strategic areas, focused on achieving greater knowledge, contributing to the resolution of real problems existing in the field of infectious diseases.

Registered Biobank Name	Biobanco de Enfermedades Infecciosas (BBEI)
Biobank Leader	Horacio Salomon
Country	Argentina
Email for biobank inquiries	hsalomon@fmed.uba.ar
Principal Investigator	Natalia Laufer
Website
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).